Target intelligence / Profile preview

PRICKLE2 antisense RNA 1 (PRICKLE2-AS1)

Target
PRICKLE2-AS1
Molecular classification
Other (long non-coding RNA, lncRNA)
01

Overview

PRICKLE2 antisense RNA 1 (PRICKLE2-AS1) is a human long non-coding RNA (lncRNA), meaning it is transcribed from the genome but does not encode a protein[1][5][6]. It is located on chromosome 3 (chr3:64024107-64103131, hg38)[1]. PRICKLE2-AS1 has been associated with epigenetic and transcriptional regulation through differential methylation patterns, particularly in certain cancers such as vulvar squamous cell carcinoma[4]. There are currently no known direct interacting drugs or established therapeutic targeting mechanisms for PRICKLE2-AS1, and it is not classified as a canonical therapeutic target such as a receptor, enzyme, transporter, or similar protein[1][5]. The main functional roles and disease associations are currently inferred from its encoded gene's expression profiles and observed differential methylation, suggesting a potential but as yet uncharacterized role in gene regulation and disease[2][4]. There is no evidence for PRICKLE2-AS1 being a misannotated or incorrect target—it is a valid lncRNA gene with supporting genomic and functional association data[1][5][6].

Other names
PRICKLE2 antisense RNA 1 (non-protein coding)PRICKLE2-AS1LINC00994
02

Biological functions

Epigenetic regulationTranscriptional regulationRegulation of gene expression (likely roles based on molecular class; direct experimental data limited)
03

Disease associations

Cancer (specifically implicated in vulvar squamous cell carcinoma via differential methylation)
04

Biomarkers

Differential methylation status (for example, as seen in vulvar squamous cell carcinoma)

Beyond the preview

Go deeper on PRICKLE2 antisense RNA 1 (PRICKLE2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRICKLE2 antisense RNA 1 (PRICKLE2-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call